In the UK, GLP-1 medications for weight management (such as Wegovy) are typically initiated within specialist weight management services according to NICE criteria
Based on Eli Lilly's public statements and the typical FDA review timeline, retatrutide approval is most likely in 2027 or early 2028
Benefits for longevity, cognitive protection, autoimmune disease, and cardiovascular prevention have not been established at below-label doses
Underlying Health Conditions & Medications What worked with others using Mounjaro might not work the same way with you
Importantly, damage to the endothelial cell layer and/or inflammatory stimuli from the peripheral blood in circulation can also prompt microglia activation and migration to the vasculature (Haruwaka et al., 2019)
however, data on clinical outcomes are limited and the risk of hyperkalaemia has hindered their widespread use